MRI The Appy | Tazo or Cefepime
The JournalFeed podcast for the week of Oct 30 Nov 3, 2023.
These are summaries from just 2 of the 5 article we cover every week! For access to more, please visit JournalFeed.org for details about becoming a member.
Tuesday Spoon Feed:
After a non-diagnostic screening ultrasound for appendicitis, a rapid-MRI has high clinical accuracy in establishing the appropriate diagnosis (appendicitis or not) in a pediatric patient population.
Friday Spoon Feed:
In this randomized control trial (RCT) of patients receiving cefepime or piperacillin-tazobactam, there was no difference in risk of acute kidney injury (AKI) between the two groups. However, those who received cefepime were more likely to have neurologic side effects.
Fler avsnitt av JournalFeed
Visa alla avsnitt av JournalFeedJournalFeed med Nick Zelt finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.